ELUTIA INC. 8-K

What Happened

• Elutia Inc. filed an 8-K on January 2, 2026 reporting that on December 23, 2025 Nasdaq’s Listing Qualifications staff notified the company it was not in compliance with Nasdaq Listing Rule 5550(b)(2) because its market value of listed securities (MVLS) fell below the $35 million requirement for the prior 30 consecutive business days.
• Nasdaq previously notified Elutia on November 7, 2025 that it was not in compliance with the $1.00 minimum bid price rule (Rule 5550(a)). The notices do not have immediate effect — Elutia’s Class A common stock continues to trade on The Nasdaq Capital Market under the symbol “ELUT” while the company seeks to regain compliance.

Key Details

• MVLS requirement: $35.0 million; company has 180 calendar days from Dec 23, 2025 (until June 22, 2026) to close at or above $35M for at least 10 consecutive business days to regain compliance.
• Bid price requirement: $1.00 closing bid for at least 10 consecutive business days; company has until May 6, 2026 (180 days from Nov 7, 2025) to cure this deficiency.
• If MVLS compliance is regained, Elutia may be eligible for a second 180‑day bid‑price cure period (which could include a reverse stock split) but only if it meets other Nasdaq initial listing standards.
• If Elutia fails to regain compliance, Nasdaq may issue a delisting notice; the company can appeal to a Nasdaq Hearings Panel under Rule 5815(a).

Why It Matters

• For investors, these notices signal a real risk of delisting from Nasdaq if Elutia cannot meet the stated market‑value or bid‑price thresholds within the cure periods. Delisting could reduce liquidity, widen bid‑ask spreads, and make shares harder to trade or finance.
• The company says it will monitor its MVLS and stock price and evaluate options to regain compliance, but the filing warns there is no assurance it can do so. Investors should watch the cure deadlines (May 6, 2026 for bid price; June 22, 2026 for MVLS) and any company actions (e.g., reverse split, financing, or other measures) that could affect compliance.